For the quarter ending 2025-09-30, BCAX has $424,688K in assets. $21,908K in debts. $171,673K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 171,673 | 436,606 | ||
| Prepaid expenses and other assets | 7,205 | 7,785 | ||
| Short term investments | 118,494 | - | ||
| Total current assets | 297,372 | 444,391 | ||
| Property and equipment, net | 135 | 117 | ||
| Right of use asset operating lease | 1,969 | 2,237 | ||
| Long term investments | 117,417 | - | ||
| Other assets | 7,795 | 6,842 | ||
| Total assets | 424,688 | 453,587 | ||
| Accounts payable-Nonrelated Party | 3,003 | 2,041 | ||
| Accounts payable-Related Party | 659 | 870 | ||
| Accrued expenses and other current liabilities-Nonrelated Party | 14,986 | 12,000 | ||
| Accrued expenses and other current liabilities-Related Party | 1,285 | 1,242 | ||
| Operating lease liability current portion | 1,095 | 1,074 | ||
| Total current liabilities | 21,028 | 17,227 | ||
| Operating lease liability net of current portion | 880 | 1,164 | ||
| Total liabilities | 21,908 | 18,391 | ||
| Common stock, 0.0001 par value, 500,000,000 and 500,000,000 shares authorized 54,612,477 and 54,444,180 shares issued and 54,612,477 and 54,440,013 shares outstanding as of september30, 2025 and december31, 2024, respectively | 7 | 7 | ||
| Additional paid-in capital | 724,489 | 720,439 | ||
| Accumulated other comprehensive loss | -136 | - | ||
| Accumulated deficit | -321,580 | -285,250 | ||
| Total stockholders' equity | 402,780 | 435,196 | ||
| Total liabilities and stockholders equity | 424,688 | 453,587 | ||
Bicara Therapeutics Inc. (BCAX)
Bicara Therapeutics Inc. (BCAX)